201 related articles for article (PubMed ID: 26114992)
1. SMARCE1 mutations in pediatric clear cell meningioma: case report.
Evans LT; Van Hoff J; Hickey WF; Smith MJ; Evans DG; Newman WG; Bauer DF
J Neurosurg Pediatr; 2015 Sep; 16(3):296-300. PubMed ID: 26114992
[TBL] [Abstract][Full Text] [Related]
2. Pediatric clear cell meningioma involving the middle cranial fossa in the context of NF2 and SMARCE1 mutations.
Libert DM; Prayson RA
Ann Diagn Pathol; 2020 Jun; 46():151516. PubMed ID: 32311644
[TBL] [Abstract][Full Text] [Related]
3. SMARCE1-related meningiomas: A clear example of cancer predisposing syndrome.
Fiorentini E; Giunti L; Di Rita A; Peraio S; Fonte C; Caporalini C; Buccoliero AM; Censullo ML; Gori G; Noris A; Pasquariello R; Battini R; Pavone R; Giordano F; Giglio S; Rinaldi B
Eur J Med Genet; 2023 Jul; 66(7):104784. PubMed ID: 37164167
[TBL] [Abstract][Full Text] [Related]
4. SMARCE1 mutation screening in classification of clear cell meningiomas.
Smith MJ; Ahn S; Lee JI; Bulman M; Plessis DD; Suh YL
Histopathology; 2017 Apr; 70(5):814-820. PubMed ID: 27891692
[TBL] [Abstract][Full Text] [Related]
5. Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas.
Smith MJ; O'Sullivan J; Bhaskar SS; Hadfield KD; Poke G; Caird J; Sharif S; Eccles D; Fitzpatrick D; Rawluk D; du Plessis D; Newman WG; Evans DG
Nat Genet; 2013 Mar; 45(3):295-8. PubMed ID: 23377182
[TBL] [Abstract][Full Text] [Related]
6. The importance of genetic counseling and screening for people with pathogenic SMARCE1 variants: A family study.
Shoakazemi A; Hewitt A; Smith MJ; du Plessis D; Thomas O; Stivaros SM; Deniz K; Hammerbeck-Ward C; Rutherford SA; King AT; Evans DG
Am J Med Genet A; 2021 Feb; 185(2):561-565. PubMed ID: 33185983
[TBL] [Abstract][Full Text] [Related]
7. Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis.
Tauziede-Espariat A; Parfait B; Besnard A; Lacombe J; Pallud J; Tazi S; Puget S; Lot G; Terris B; Cohen J; Vidaud M; Figarella-Branger D; Monnien F; Polivka M; Adle-Biassette H; Varlet P
Brain Pathol; 2018 Jul; 28(4):466-474. PubMed ID: 28474749
[TBL] [Abstract][Full Text] [Related]
8. Pediatric intracranial clear cell meningioma associated with a germline mutation of SMARCE1: a novel case.
Raffalli-Ebezant H; Rutherford SA; Stivaros S; Kelsey A; Smith M; Evans DG; Kilday JP
Childs Nerv Syst; 2015 Mar; 31(3):441-7. PubMed ID: 25249420
[TBL] [Abstract][Full Text] [Related]
9. Germline and somatic mutations in meningiomas.
Smith MJ
Cancer Genet; 2015 Apr; 208(4):107-14. PubMed ID: 25857641
[TBL] [Abstract][Full Text] [Related]
10. Spinal clear cell meningioma in a 3-year-old: a case report.
Balogun JA; Halliday W; Bouffet E; Kulkarni AV
Pediatr Neurosurg; 2013; 49(5):311-5. PubMed ID: 25377168
[TBL] [Abstract][Full Text] [Related]
11. Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.
Smith MJ; Wallace AJ; Bennett C; Hasselblatt M; Elert-Dobkowska E; Evans LT; Hickey WF; van Hoff J; Bauer D; Lee A; Hevner RF; Beetz C; du Plessis D; Kilday JP; Newman WG; Evans DG
J Pathol; 2014 Dec; 234(4):436-40. PubMed ID: 25143307
[TBL] [Abstract][Full Text] [Related]
12. Intramedullary clear cell meningioma.
Park SH; Hwang SK; Park YM
Acta Neurochir (Wien); 2006 Apr; 148(4):463-6. PubMed ID: 16341630
[TBL] [Abstract][Full Text] [Related]
13. Familial Pediatric Clear Cell Meningioma With Germline SMARCE1 Mutation in the United States.
Navalkele P; Guzman M; Kirby A; Pinz H; Kemp J
J Neuropathol Exp Neurol; 2020 Nov; 79(11):1250-1252. PubMed ID: 33085974
[No Abstract] [Full Text] [Related]
14. Spinal intradural clear cell meningioma following resection of a suprasellar clear cell meningioma. Case report and recommendations for management.
Dhall SS; Tumialán LM; Brat DJ; Barrow DL
J Neurosurg; 2005 Sep; 103(3):559-63. PubMed ID: 16235691
[TBL] [Abstract][Full Text] [Related]
15. Cervical spine meningioma presenting as otalgia: case report.
Danish SF; Zager EL
Neurosurgery; 2005 Mar; 56(3):E621; discussion E621. PubMed ID: 15730588
[TBL] [Abstract][Full Text] [Related]
16. Pediatric spinal clear cell meningioma. Case report.
Colen CB; Rayes M; McClendon J; Rabah R; Ham SD
J Neurosurg Pediatr; 2009 Jan; 3(1):57-60. PubMed ID: 19119906
[TBL] [Abstract][Full Text] [Related]
17. Hereditary clear cell meningiomas in a single family: three-cases report.
Inoue T; Shitara S; Ozeki M; Nozawa A; Fukao T; Fukushima T
Acta Neurochir (Wien); 2018 Dec; 160(12):2321-2325. PubMed ID: 30421029
[TBL] [Abstract][Full Text] [Related]
18. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
[TBL] [Abstract][Full Text] [Related]
19. Spinal cartilaginous meningioma in a child: a case report.
Ijiri R; Hara M; Tanaka Y; Kato K; Sekido K
Childs Nerv Syst; 2000 Feb; 16(2):80-3. PubMed ID: 10663811
[TBL] [Abstract][Full Text] [Related]
20. SMARCE1 deficiency generates a targetable mSWI/SNF dependency in clear cell meningioma.
St Pierre R; Collings CK; Samé Guerra DD; Widmer CJ; Bolonduro O; Mashtalir N; Sankar A; Liang Y; Bi WL; Gerkes EH; Ramesh V; Qi J; Smith MJ; Meredith DM; Kadoch C
Nat Genet; 2022 Jun; 54(6):861-873. PubMed ID: 35681054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
